Introduction of human papillomavirus vaccination in Nordic countries

Vaccine

Volumn 30, Issue 8, 2012, Pages 1425-1433

  Sander, Bente Braad ^a   Rebolj, Matejka ^a   Valentiner Branth, Palle ^b   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Cervical cancer; Coverage; HPV vaccination; Nordic countries

Indexed keywords

WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; DENMARK; DRUG COST; FINLAND; GREENLAND; GROUPS BY AGE; HUMAN; ICELAND; NORWAY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SWEDEN; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

EUROPE; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84856574537     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.097     Document Type: Review

References (134)

1. International Agency for Research of Cancer IARC handbook of cancer prevention. Cervix cancer screening 2005, vol. 10. IARC Press, Lyon.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. European Medicines Agency. European public assessment report for Cervarix. Available from: [last accessed 26.08.11]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000721/WC500024634.pdf.
4. European Medicines Agency. European public assessment report for Gardasil. Available from: [last accessed 26.08.11]. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000703/WC500021146.pdf.
5. Garland S.M., Smith J.S. Human papillomavirus vaccines: current status and future prospects. Drugs 2010, 70:1079-1098.
6. Garland S.M., Steben M., Sings H.L., James M., Lu S., Railkar R., et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 2009, 199:805-814.
7. Socialstyrelsen. Background to a vaccination programme for the human papilloma virus in Sweden 2007. Available from: [last accessed 16.11.11]. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8868/2008-132-2_20081322.pdf.
8. De Carvalho N., Teixeira J., Roteli-Martins C.M., Naud P., De Borba P., Zahaf T., et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine 2010, 28:6247-6255.
9. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Paavonen J., Iversen O.E., et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006, 95:1459-1466.
10. Hildesheim A., Herrero R., Wacholder S., Rodriguez A.C., Solomon D., Bratti M.C., et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007, 298:743-753.
11. Legemiddelverket. Preparatsok Gardasil [Search for product, Gardasil]. Available from: [last accessed 26.08.11]. http://legemiddelverket.no/custom/Preparatsok/prepSearch____80333.aspx%3FSearchID=d2652f9c-6e7c-48c1-a8d8-fde3d5a824b5.
12. Legemiddelverket. Preparatsok Cervarix [Search for product, Cervarix]. Available from: [last accessed 26.08.11]. http://legemiddelverket.no/custom/Preparatsok/prepSearch____80333.aspx%3FSearchID=0c486400-0ffd-4f1d-a109-7611bf06fc19.
13. Norden. The Nordic countries in figures 2010. Available from: [last accessed 16.11.11]. http://www.norden.org/en/publications/publikationer/2010-773.
14. Nordisk Medicinalstatistisk Komité. Helsestatistik for de nordiske lande med data fra 2008 [Health Statistics in the Nordic Countries with data from 2008]. Available from: [last accessed 26.08.11]. http://nomesco-da.nom-nos.dk/filer/publikationer/Helsestatistik2010.pdf.
15. World Bank. GDP per capita (current US$). Available from: [last accessed 26.08.11]. http://data.worldbank.org/indicator/NY.GDP.PCAP.CD/countries.
16. EUVAC. National childhood vaccination schedules. Available from: [last accessed 26.08.11]. http://www.euvac.net/graphics/euvac/vaccination/vaccination.html.
17. Naalakkersuisut. Forebyggende børneundersøgelser og børnevaccinationer i Grønland 2010 [Preventive childhood health visits and childhood vaccinations in Greenland 2010]. Available from: [last accessed 26.08.2011]. http://www.peqqik.gl/Publikationer/~/media/ELI/Boernevaccinationsprogram2010/vaccinationsprogram%20DK_endelig.ashx.
18. Statens Serum Institut. MMR vaccination coverage 2010 Epi-News No. 21-2011. Available from: [last accessed 26.08.11]. http://www.ssi.dk/English/News/EPI-NEWS/2011/No%2021%20-%202011.aspx.
19. National Institute for Health and Welfare. Vaccination coverage. Available from: [last accessed 26.08.11]. http://www.ktl.fi/portal/english/research__people___programs/vaccines/vaccination_coverage/.
20. Landslægeembedet. Landslægeembedets årsberetning 2008 [Annual report of the chief physician in Greenland]. Available from: [last accessed 19.08.11]. http://dk.nanoq.gl/Emner/Landsstyre/Departementer/Landslaegeembedet/Udgivelser/Aarsberetning/~/media/4043C6719A814D608598074A549614B9.ashx.
21. The Directorate of Health. Annus medicus 2009 Iceland. Extract from the annual report of the Directorate of Health 2009. Available from: [last accessed 18.08.11]. http://www.landlaeknir.is/lisalib/getfile.aspx%3Fitemid=4562.
22. Folkehelseinstituttet. Barnevaksinasjon [Childhood vaccination]. Available from: [last accessed 01.09.11]. http://www.fhi.no/dokumenter/2d9b3917b3.pdf.
23. Smittskyddsinstitutet. Vaccinationsrapport från skolhälsovården läsåret 2008/2009 [Vaccination report from the school health system for school year 2008/2009]. Available from: [last accessed 26.08.11]. http://www.smittskyddsinstitutet.se/upload/5215/la-08-09-vaccstat-skolh-tabeller.pdf.
24. Engholm G, Ferlay J, Christensen N, Gjerstorff ML, Johannesen TB, Klint å, et al. (2011). NORDCAN: Cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 4.0. Association of the Nordic Cancer Registries, Danish Cancer Society. Available from: [last accessed 26.08.11]. http://www.ancr.nu/.
25. Sundhedsstyrelsen. Screening for livmoderhalskræft [Screening for cervical cancer]. Available from: [last accessed 26.08.11]. http://www.sst.dk/publ/Publ2007/PLAN/Kraeft/Anbef_screen_livmoderhals.pdf.
26. Sundhedsstyrelsen. Reduktion af risikoen for livmoderhalskræft ved vaccination mod humant papillomvirus (HPV) - en medicinsk teknologivurdering [Reduction of the risk of cervical cancer with vaccination against Human Papillomavirus (HPV) - a health technology assessment]. Available from: [last accessed 26.08.11]. http://www.sst.dk/publ/Publ2007/MTV/HPV/HPV_vaccination.pdf.
27. Smith E, Poulsen S. Indstilling vedr. indførelse af humant papillomavirus (HPV)-vaccination i Det danske Børnevaccinationsprogram [Recommendation concerning introduction of the human papillomavirus (HPV) vaccine into the Danish childhood vaccination program]. Available from: [last accessed 21.11.11]. http://www.sst.dk//~/media/Sundhed%20og%20forebyggelse/Vaccinationer/HPV/indstillling_hpvvaccine_4okt07.ashx.
28. Sundhedsstyrelsen. 105.000 piger får invitation til ny gratis vaccination mod livmoderhalskræft [105,000 girls will get an invitation for free vaccination against cervical cancer]. Available from: [last accessed 26.08.11]. http://www.sst.dk/Nyhedscenter/Nyheder/2008/HPV_vaccination_september2008.aspx.
29. Hviid A. Postlicensure epidemiology of childhood vaccination: the Danish experience. Expert Rev Vaccines 2006, 5:641-649.
30. Valentiner-Branth P, Widgren K, Andersen PH, Glismann S, Simonsen J. HPV vaccination, coverage 2010, Epi-news No. 18-2011. Available from: [last accessed 26.08.11]. http://www.ssi.dk/English/News/EPI-NEWS/2011/No%2018%20-%202011.aspx.
31. Statens Serum Institut. Det Danske Vaccinationsregister [The Danish Vaccination Register]. Available from: [last accessed 25.08.11]. http://www.medcom.dk/dwn3121.
32. Ministeriet for sundhed og forebyggelse. Bred enighed om vaccine mod livmoderhalskræft [Consensus about the vaccine against cervical cancer]. Available from: [last accessed 09.11.11]. http://www.im.dk/Aktuelt/Nyheder/Sundhedspolitik/2009/Juni/bred%20enighed.aspx.
33. Møbjerg L. Kritik af forslag om kræftvaccine [Criticism of the proposal about cancer vaccine]. Available from: [last accessed 17.08.11]. http://www.dr.dk/Nyheder/Indland/2008/02/07/082225.htm.
34. Sundhedsstyrelsen. HPV-vaccine mod livmoderhalskræft og kønsvorter [HPV vaccine against cervical cancer and genital warts]. Available from: [last accessed 30.08.11]. http://www.sst.dk/Sundhed%20og%20forebyggelse/Vaccinationer/HPV%20vaccination.aspx.
35. Heissel A. Staten sparer 50 mio kr ved ny udbudsrunde [The government saves 50 million Kroner with a new tender]. Available from: [last accessed 29.07.11]. http://www.dagensmedicin.dk/nyheder/2011/04/15/staten-sparer-50-mio-kr-pa/index.xml.
36. Wennerstrøm J. Skab opmærksomhed om vaccination for livmoderhalskræft [Create attention towards the vaccination against cervival cancer]. Available from: [last accessed 26.08.11]. http://www.cancer.dk/stoet+os/hjaelp+frivillige/Laes+om+de+frivillige/frivillignyt/frivillignyt+artikler/2007_2/HPV-vaccine.htm.
37. Vang R. Vaccine mod livmoderhalskræft virker på kvinder mellem 18 og 26 år [The vaccine against cervical cancer has an effect on women from 18 to 26 years of age]. Available from: [last accessed 26.08.11]. http://www.cancer.dk/stoet+os/hjaelp+frivillige/Laes+om+de+frivillige/RegionsudvalgsNyt/artikler/2010/vaccine.htm.
38. Ludvigsen MB. Høj pris får unge til at vælge HPV-vaccine fra [High price is the reason for youngsters not choosing the HPV vaccine]. Available from: [last accessed 26.08.11]. http://www.cancer.dk/Nyheder/nyhedsartikler/2011kv1/ungebliverikkevaccineret.htm.
39. Felsby O. DSOG. Aldersgrænsen skal hæves for piger, som kan få HPV-vaccine [Danish Association of Obstetrics and Gynecology: The age limit for HPV vaccination for girls should be raised]. Available from: [last accessed 17.08.11]. http://www.dagensmedicin.dk/nyheder/2009/04/26/dsog-aldersgrnsen-skal-hve/.
40. Aagaard P. Læger advarer mod hastværk med kræftvaccine [Doctors warn against haste with cancer vaccine]. Available from: [last accessed 29.08.11]. http://www.dagensmedicin.dk/nyheder/2008/02/07/lger-advarer-mod-at-presse/index.xml.
41. Indenrigsministeriet og Sundhedsministeriet. HPV vaccine op til 26 år [HPV vaccine up to the age of 26]. Available from: [last accessed 15.08.11]. http://www.im.dk/Aktuelt/Nyheder/Kraeft/2011/August/HPV_vaccination_26_aar.aspx.
42. Regeringen. Ansvar og handling, Oplæg til finanslov 2012 [Liability and action, Proposal for the budget 2012]. Available from: [last accessed 07.11.11]. http://fm.dk/Publikationer/2011/~/media/Publikationer/Imported/2011/Ansvar%20og%20handling/ansvar%20og%20handling_web.ashx.
43. Willumsen G. Vaccine mod kræft udløser etisk dilemma [Vaccine against cancer triggers an ethical dilemma]. Available from: [last accessed 17.08.11]. http://ing.dk/artikel/80248-vaccine-mod-kraeft-udloeser-etisk-dilemma.
44. GSK. Indførelse af livmoderhalskræftvaccine i børnevaccinationsprogrammet [Introduction of the vaccine against cervical cancer in the childhood vaccination program]. Available from: [last accessed 29.08.11]. http://www.ft.dk/samling/20071/almdel/SUU/Bilag/28/404607.PDF.
45. Heissel A. GSK vinder over konkurrent i tvist om kræftvaccine [GSK wins over competitor in dispute about the cancer vaccine]. Available from: [last accessed 17.08.11]. http://www.dagensmedicin.dk/nyheder/2011/01/12/gsk-vinder-over-konkurrent/index.xml.
46. Harper D.M., Nieminen P., Paavonen J., Lehtinen M. Cervical cancer incidence can increase despite HPV vaccination. Lancet Infect Dis 2010, 10:594-595.
47. Dorleans F., Giambi C., Dematte L., Cotter S., Stefanoff P., Mereckiene J., et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010, 15.
48. Syrjanen K.J. Prophylactic HPV vaccines: the Finnish perspective. Expert Rev Vaccines 2010, 9:45-57.
49. Terveyden ja hyvinvoinnin laitos. Terveyden ja hyvinvoinnin laitoksen asettaman papilloomavirustautien torjuntatyöryhmän selvitys [Report of the study by the Expert Group on Papillomavirus Disease Prevention appointed by the National Institute for Health and Welfare]. Available from: [last accessed 17.08.11]. http://www.thl.fi/thl-client/pdfs/94d6f45d-22e1-4b53-b615-2eea48d90e1c.
50. Terveyden ja hyvinvoinnin laitos. THL esittää HPV-rokotetta rokotusohjelmaan ja kohdunkaulan syövän seulonnan tehostamista [THL proposes HPV vaccination to be added to the vaccination program, and for the effectiveness of the cervical cancer screening program to be improved]. Available from: [last accessed 20.10.11]. http://www.thl.fi/fi_FI/web/fi/tiedote%3Fid=25746.
51. Syöpäjärjestöt. Syöpäjärjestöjen näkemys HPV-rokotteesta [Cancer Society's view of HPV vaccine]. Available from: [last accessed 29.08.11]. http://www.cancer.fi/@Bin/24158703/Sy%25C3%25B6p%25C3%25A4j%25C3%25A4rjest%25C3%25B6jen+n%25C3%25A4kemys+HPV-rokotteesta.pdf.
52. World Health Organization. Health policy for children and adolescents, No. 5: Inequalities in young people's health. Health behaviour in school-aged children. International report from the 2005/2006 survey. Available from: [last accessed 29.08.11]. http://www.euro.who.int/__data/assets/pdf_file/0005/53852/E91416.pdf.
53. Nielsen N.H., Jensen H. Screening for cancer of the uterine cervix in Greenland. APMIS 1993, 101:290-294.
54. Nakorsanut. Meddelelser fra Grønlands Lægekredsforening. Tema: Screening i Grønland [Theme: Screening in Greenland]. Available from: [last accessed 29.08.11]. http://www.laeger.dk/portal/page/portal/LAEGERDK/Laegerdk/Om%20L%C3%A6geforeningen/L%C3%A6gekredsforeningen%20Gr%C3%B8nland/Nakorsanut%20-%20LKFs%20medlemsblad/Nakorsanut_1_2010.pdf.
55. Arbejdsgruppen om HPV vaccination i Grønland. Forslag til Landstingsbeslutning om, at Landsstyret pålægges at indføre vaccine til reduktion af risiko for/forebyggelse af livmoderhalskræft [Recommendation to the home rule government to introduce vaccination to prevent cervical cancer]. Available from: [last accessed 31.07.11]. http://cms.inatsisartut.gl/upload/labu/em2007/svarnotater/pkt161_sn_dk.pdf.
56. Krebs ML. Kræftvaccine på vej [Cancer vaccine on its way]. Available from: [last accessed 29.08.11]. http://www.knr.gl/da/news/kr%25C3%25A6ftvaccine-p%25C3%25A5-vej.
57. Kleemann LM. HPV-vaccine kun til piger [HPV vaccine only for girls]. Available from: [last accessed 28.02.11]. http://knr.gl/kl/node/40359.
58. Grønlands hjemmestyre, departementet for Familie og Sundhed. Værd at vide om HPV-vaccination mod livmoderhalskræft og kønsvorter [Worth knowing about HPV vaccination against cervical cancer and genital warts]. Available from: [last accessed 29.08.11]. http://www.peqqik.gl/Sundhed/~/media/DS/PDF%20filer/DS/HPV/0812_HPV_press.ashx.
59. Landslægeembedet. Landslægeembedets årsberetning 2009 [Annual report of the chief physician in Greenland]. Available from: [last accessed 29.08.11]. http://dk.nanoq.gl/Emner/Landsstyre/Departementer/Landslaegeembedet/Udgivelser/Aarsberetning/~/media/6442BDE657B2444C864FE136F6951102.ashx.
60. Sigurdsson K. Cervical cancer: cytological cervical screening in Iceland and implications of HPV vaccines. Cytopathology 2010, 21:213-222.
61. Oddsson K., Johannsson J., Asgeirsdottir T.L., Gudnason T. Cost-effectiveness of human papilloma virus vaccination in Iceland. Acta Obstet Gynecol Scand 2009, 88:1411-1416.
62. Althingi. Fjárlög 2011 [The budget for 2011]. Available from: [last accessed 29.08.11]. http://www.althingi.is/raeda/139/rad20101215T112826.html.
63. Kreftregisteret. Special issue. Cancer screening in Norway. Available from: [last accessed 22.11.11]. http://www.kreftregisteret.no/Global/Publikasjoner%20og%20rapporter/Special%20Issue/Special_Issue_Cancer_in_Norway_2009.pdf.
64. Folkehelseinstituttet. Folkehelseinstituttet anbefaler HPV-vaksinen innført i vaksinasjonsprogrammet [The National Institute of Public Health recommends that the HPV vaccine should be included in the vaccination programme]. Available from: [last accessed 03.01.11]. http://www.fhi.no/eway/default.aspx%3Fpid=233%26trg=Area_5774%26MainArea_5661=5565%3A0%3A15,1223%3A1%3A0%3A0%3A0%3A0%26MainLeft_5565=5774%3A0%3A15,1223%3A1%3A0%3A0%3A0%3A0%26Area_5774=5544%3A64511%3A1%3A5776%3A1%3A0%3A0.
65. Folkehelseinstituttet. årsrapport for HPV-vaksine i barnevaksinasjonsprogrammet 2009/2010 [Yearly report on HPV vaccination in the childhood vaccination program 2009/2010). Available from: [last accessed 29.08.11]. http://www.fhi.no/dokumenter/9b6754addc.pdf.
66. Folkehelseinstittutet. Informasjonsbrev til foreldre/jenter om utvidet tilbud om HPV-vaksine [Information letter to parents/girls about an extended offer on the HPV vaccine]. Available from: [last accessed 05.09.11]. http://www.fhi.no/dokumenter/31e1e2430f.pdf.
67. Cancer Registry of Norway. HPVnorvaks. National follow-up of the HPV vaccination program. Available from: [last accessed 29.08.11]. http://kreftregisteret.no/en/Research/Projects/-HPVnorvaks/.
68. Folkehelseinstituttet. Statistikk HPV - vaksinasjon [Statistics about HPV vaccination]. Available from: [last accessed 03.11.11]. http://www.fhi.no/dokumenter/100d2bb0c6.pdf.
69. Storvik AG. Foreslår HPV-vaksine på blåresept [Recommending HPV vaccine for blue prescription]. Available from: [last accessed 29.08.11]. http://www.dagensmedisin.no/nyheter/2010/09/21/foreslar-hpv-vaksine-pa-bl/index.xml.
70. Stølan J. I sterk vaksinetvil [Strongly in doubt about vaccination]. Available from: [last accessed 18.08.11]. http://www.vg.no/helse/artikkel.php%3Fartid=517003.
71. Gjerding ML. Helsetopp vil ikke kreftvaksinere eget barnebarn [Health leader will not vaccinate her own grandchild]. Available from: [last accessed 18.08.11]. http://www.vg.no/helse/artikkel.php%3Fartid=571352.
72. Lundh F. Hanssen - Ville ikke tvilt et sekund på kreftvaksinen [Hanssen: I would not doubt one second about the cancer vaccine]. Available from: [last accessed 18.08.11]. http://www.vg.no/helse/artikkel.php%3Fartid=541748.
73. Høstmælingen N. HPV-vaksine - naivt og velment? [HPV vaccine, naively and well-intentioned?]. Available from: [last accessed 29.08.11]. http://www.tidsskriftet.no/article/1809620.
74. Stølan J, Johnsrud I. Fikk betalt av vaksineprodusent [Was paid by the vaccine producers]. Available from: [last accessed 18.08.11]. http://www.vg.no/nyheter/innenriks/artikkel.php%3Fartid=167501.
75. Haug C. Prioritering på papiret - og i praksis [Prioritizing on paper - and in practice]. Available from: [last accessed 29.08.11]. http://www.tidsskriftet.no/index.php%3Fseks_id=1677930.
76. Hanger MR, Henriksen K, Dommerud T. HPV-vaksinen til rikmannsdøtre [HPV vaccine for rich people's daughters]. Available from: [last accessed 18.08.11]. http://www.dagensmedisin.no/nyheter/2007/11/29/hpv-vaksinen-til-rikmannsd/index.xml.
77. Storvik AG. Tusenvis krever HPV-vaksine [Thousands demand HPV vaccine]. Available from: [last accessed 19.10.11]. http://www.dagensmedisin.no/nyheter/2008/08/21/tusenvis-krever-hpv-vaksin/index.xml.
78. Anttila A., Ronco G. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009, 45:2685-2708. Working Group on the Registration and Monitoring of Cervical Cancer Screening Programmes in the European Union; within the European Network for Information on Cancer.
79. Anttila A., von Karsa L., Aasmaa A., Fender M., Patnick J., Rebolj M., et al. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009, 45:2649-2658.
80. Dillner J, Andrae B, Westermark B. Svensk konsensus om vaccination mot cervixcancer 2007 [Swedish consensus on vaccination against cervical cancer 2007]. Available from: [last accessed 29.08.11]. http://www.lakartidningen.se/engine.php%3FarticleId=5208.
81. SBU alert. Allmän barnvaccination mot HPV 16 och 18 i syfte att förebygga livmoderhalscancer [General vaccination of children against HPV 16 and 18 in order to prevent cervical cancer]. Available from: [last accessed 04.11.11]. http://www.sbu.se/upload/Publikationer/Content0/3/Allman_barnvaccination_HPV_16_18_forebygga_livmoderhalscancer_200801.pdf.
82. Socialstyrelsen. Rekommendationer för vaccination mot humant papillomvirus [Recommendations for vaccination against Human Papillomavirus]. Available from: [last accessed 04.11.11]. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18113/2010-9-6.pdf.
83. Tegnell A., Dillner J., Andrae B. Introduction of human papillomavirus (HPV) vaccination in Sweden. Euro Surveill 2009, 14.
84. Ohlin E. HPV-vaccin utan kondylomskydd vann upphandling [HPV vaccine without protection against genital warts won the tender]. Available from: [last accessed 31.03.11]. http://www.lakartidningen.se/engine.php%3FsectionId=0%26articleId=13997.
85. Ohlin E. Läkarförbundet vill HPV-vaccinera mot kondylom [The Medical Society will vaccinate against genital warts]. Available from: [last accessed 29.08.11]. http://www.lakartidningen.se/07engine.php%3FarticleId=9501.
86. Rylander E. Kortsiktig ekonomi bakom val av HPV-vaccin [Short sighted economics behind the choice of HPV vaccine]. Available from: [last accessed 18.02.11]. http://www.lakartidningen.se/07engine.php%3FarticleId=14641.
87. Ohlin E. Upphandlingen av HPV-vaccin stoppad [The tender of HPV vaccine has been stopped]. Available from: [last accessed 19.08.11]. http://www.lakartidningen.se/07engine.php%3FarticleId=14059.
88. Stiernstedt G, Claesson B. Ny upphandling av HPV-vaccin [A new tender for the HPV vaccine]. Available from: [last accessed 08.09.11]. http://www.skl.se/press/nyheter_2/ny-upphandling-av-hpv-vaccin.
89. Claesson B. Landstingen väljer Gardasil [The county chooses Gardasil]. Available from: [last accessed 07.11.11]. http://www.skl.se/press/pressmeddelanden/landstingen-vill-valja-gardasil.
90. Thor J, Flaten O. Landstingens kovändning ökar cancerrisk hos flickor [The U-turn of the county increases the cancer risk among girls]. Available from: [last accessed 07.11.11]. http://www.dn.se/Pages/Article.aspx%3Fid=685358__Article%26epslanguage=sv.
91. Wärngård M. Stockholm köper också HPV-vaccin [Stockholm is also buying HPV vaccine]. Available from: [last accessed 07.11.11]. http://www.dagensapotek.se/politik--samhalle/stockholm-koper-ocksa-hpv-vaccin.
92. European Centre for Disease Control and Prevention. Guidance for the introduction of HPV vaccines in EU countries. Available from: [last accessed 29.08.11]. http://www.ecdc.europa.eu/en/publications/Publications/0801_GUI_Introduction_of_HPV_Vaccines_in_EU.pdf.
93. World Health Organization. Weekly epidemiological record No. 15, 2009 WHO position paper on human papillomavirus vaccines. Available from: [last accessed 29.08.11]. http://www.who.int/wer/2009/wer8415.pdf.
94. Mortensen G.L. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health 2010, 10:68.
95. Mortensen G.L. Parental attitudes towards vaccinating sons with human papillomavirus vaccine. Danish Med Bull 2010, 57:A4230.
96. Burgess D.C., Burgess M.A., Leask J. The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?. Vaccine 2006, 24:3921-3928.
97. Zilstorff L. HPV-vaccine bør tilbydes alle kvinder op til 26 år [HPV vaccine should be offered to all women until age 26]. Available from: [last accessed 07.02.08]. http://www.cancer.dk/Cancer/Nyheder/2008kv1/HPVvaccine.htm.
98. Hemmingsen MA. Kræftens Bekæmpelse Vaccine kan forebygge 2000 kræfttilfælde [Danish Cancer Society: Vaccine can prevent 2000 cases of cancer]. Available from: [last accessed 15.08.11]. http://www.dagensmedicin.dk/nyheder/2011/08/12/kraeftens-bekaempelse-vacc/index.xml.
99. Kræftens Bekæmpelse. Nyhedsartikler [News items]. Available from: [last accessed 29.08.11]. http://www.cancer.dk/Nyheder/nyhedsartikler/nyhedsartikler.htm.
100. Haas M., Ashton T., Blum K., Christiansen T., Conis E., Crivelli L., et al. Drugs, sex, money and power: an HPV vaccine case study. Health Policy 2009, 92:288-295.
101. Ritzau. Flere kvinder får tilbudt kræftvaccine [More women will get offered the cancer vaccine]. Available from: [last accessed 18.08.11]. http://www.dr.dk/Nyheder/Indland/2011/08/11/102621.htm.
102. Helmerhorst T.J., Meijer C.J. Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD. Int J Gynecol Cancer 2002, 12:235-236.
103. Laurent-Ledru V., Thomson A., Monsonego J. Civil society: a critical new advocate for vaccination in Europe. Vaccine 2011, 29:624-628.
104. Koulova A., Tsui J., Irwin K., Van Damme P., Biellik R., Aguado M.T. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008. Vaccine 2008, 26:6529-6541.
105. Wong C.A., Saraiya M., Hariri S., Eckert L., Howlett R.I., Markowitz L.E., et al. Approaches to monitoring biological outcomes for HPV vaccination: challenges of early adopter countries. Vaccine 2011, 29:878-885.
106. FitzSimons D., Vorsters A., Hoppenbrouwers K., Van Damme P. Prevention and control of viral hepatitis through adolescent health programmes in Europe. Vaccine 2007, 25:8651-8659. Viral Hepatitis Prevention Board; European Union for School and University Health and Medicine.
107. Folkehelseinstituttet. Barnevaksinasjonsprogrammet i Norge [The childhood vaccination programme in Norway]. Available from: [last accessed 29.08.11]. http://www.fhi.no/eway/default.aspx%3Fpid=233%26trg=MainArea_5661%26MainArea_5661=5631%3A0%3A15,4537%3A1%3A0%3A0%3A0%3A0%26MainLeft_5565=5544%3A41925%3A1%3A5689%3A1%3A0%3A0.
108. The Information Services Division. Provisional HPV Immunisation Uptake Statistics Year 3 of the HPV Immunisation Programme (2010/11]. Available from: [last accessed 02.09.11]. http://www.isdscotland.scot.nhs.uk/Health-Topics/Child-Health/Publications/2011-03-24/110324-HPV-Immunisation-Report.pdf%3F16874331236.
109. Department of Health. Annual HPV vaccine coverage in England in 2009/2010. Available from: [last accessed 02.09.11]. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_123826.pdf.
110. Ministerio de Sanidad, Política Social e Igualdad. Coberturas de Vacunación. Datos estadísticos [Vaccination coverage. Statistical data]. Available from: [last accessed 29.08.11]. http://www.mspsi.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/coberturas.htm.
111. InŠtitut za varovanje zdravja Republike Slovenije. Precepljenost (deleŽ cepljenih) deklic 6. razredov OŠ s 3 odmerki cepiva proti HPV, Šolsko leto 2009/20010 [Immunization (vaccination coverage) of girls in the 6th grade of elementary school with three doses of the vaccine against HPV, school year 2009/2010]. Available from: [last accessed 08.09.11]. http://www.ivz.si/Mp.aspx%3Fni=201%26pi=5%26_5_id=1399%26_5_PageIndex=0%26_5_groupId=322%26_5_newsCategory=%26_5_action=ShowNewsFull%26pl=201-5.0.
112. Unidade de Saúde Pública. Programa de vacinaçâo relatório de actividades-2009 [Activity report of the vaccination program 2009]. Available from: [last accessed 29.08.11]. http://www.centrodesaudedetabua.pt/imagens/novidades/50.pdf.
113. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: A multilevel study. Vaccine 2010, 28:2070-2075.
114. van Leeuwen DF, Habbema D. Is vaccinatie voorbarig of is twijfel ook wel eens dodelijk? [Is vaccination premature or can doubt be deadly?]. Available from: [last accessed 16.06.11]. http://vorige.nrc.nl/opinie/article2180532.ece/Is_vaccinatie_voorbarig_of_is_twijfel_ook_wel_eens_dodelijk.
115. NU. Opkomst vaccinatie baarmoederhalskanker valt tegen [Coverage with vaccination against cervical cancer is disappointing]. Available from: [last accessed 19.08.11]. http://www.nu.nl/algemeen/1930130/opkomst-vaccinatie-baarmoederhalskanker-valt-tegen.html.
116. Dommerud T. Færre enn 30 prosent vil HPV-vaksineres [Fewer than 30% want to receive HPV vaccine]. Available from: [last accessed 18.08.11]. http://www.dagensmedisin.no/nyheter/2009/11/12/faerre-enn-30-prosent-vil-/index.xml.
117. Brodersen J, Hovelius B, Hvas L. Skapar Vården Ohälsa? Allmänmedicinska refleksioner [Does health care create poor health? Reflections from general practice]. Studentlitteratur, 2009.
118. Gottfredsdottir H., Bjornsdottir K. 'Have you had the test?.' A discourse analysis of media presentation of prenatal screening in Iceland. Scand J Caring Sci 2010, 24:414-421.
119. Marttala J., Ranta J.K., Kaijomaa M., Nieminen P., Laitinen P., Kokkonen H., et al. More invasive procedures are done to detect each case of Down's syndrome in younger women. Acta Obstet Gynecol Scand 2011, 90:642-647.
120. Ruijs W.L., Hautvast J.L., van der Velden K., de Vos S., Knippenberg H., Hulscher M.E. Religious subgroups influencing vaccination coverage in the Dutch Bible belt: an ecological study. BMC Public Health 2011, 11:102.
121. Forster A., Wardle J., Stephenson J., Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun 2010, 15:205-217.
122. Wynia M.K. Public health, public trust and lobbying. Am J Bioeth 2007, 7:4-7.
123. ClinicalTrials.gov. Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001). Available from: [last accessed 26.08.11]. http://clinicaltrials.gov/ct2/show/NCT00543543.
124. Danmarks Statistik. Statistikbanken, befolkning og valg [Statistics Bank, population and elections]. Available from: [last accessed 30.08.11]. http://www.statistikbanken.dk/statbank5a/default.asp%3Fw=1280.
125. Statistics Finland. Statistics Finland's PX-Web databases. Available from: [last accessed 30.08.11]. http://pxweb2.stat.fi/database/StatFin/vrm/vaerak/vaerak_en.asp.
126. Grønlands statistik. Befolkningen i lokaliteterne 1. januar efter lokalitet, køn, alder og fødested 1977-2011. [Population on 1 January by area, sex, age and place of birth 1977-2011]. Available from: http://bank.stat.gl/Dialog/varval.asp?ma=BEDST4&path=./Database/Grønland/Befolkning/Folketal&lang=4 [last accessed 30.08.11].
127. Statistics Iceland. Population by origin, sex, age and citizenship 1996-2011. Available from: = [last accessed 09.09.11]. http://www.statice.is/%3FPageID=1170%26src=/temp_en/Dialog/varval.asp%3Fma=MAN00101%26ti=Population+by+sex+and+age+1841-2011+%26path=./Database/mannfjoldi/Yfirlit/%26lang=1%26units.
128. Statistisk Centralbyrå. Folkemengd etter kjønn, alder og sivilstand 1 januar 2011 [Population by sex, age and civil status on 1 January 2011]. Available from: [last accessed 30.08.11]. http://www.ssb.no/folkemengde/tab-2011-03-11-34.html.
129. Statistiska Centralbyrån. Sveriges befolkning efter kön och ålder 31 december 2010 [Population of Sweden by sex and age on 31 December 2010]. Available from: [last accessed 09.09.11]. http://www.scb.se/Pages/TableAndChart____262459.aspx.
130. Folkehelseinstituttet. Resultattabeller ungdomsundersøkelsene [Tables with results from surveys on adolescents]. Available from: [last accessed 30.08.11]. http://www.fhi.no/eway/default.aspx%3Fpid=233%26trg=MainArea_5661%26MainArea_5661=5631%3A0%3A15,4131%3A1%3A0%3A0%3A0%3A0%26MainLeft_5565=5544%3A44661%3A1%3A5590%3A2%3A0%3A0.
131. Dansk Kvalitetsdatabase for Livmoderhalskræftscreening. årsrapport DKLS 2010 [Yearly report from the Danish Quality Database on Cervical Screening 2010]. Available from: [last accessed 30.08.11]. https://www.sundhed.dk/Fil.ashx%3Fid=15486%26ext=pdf%26navn=DKLS_aarsrapport_2010.pdf.
132. Kansanterveyslaitoksen julkaisuja. Lisääntymisterveys Suomessa Terveys 2000-tutkimus [Reproductive health in Finland. The Health 2000 survey]. Available from: [last accessed 30.08.11]. http://www.terveys2000.fi/julkaisut/lister.pdf.
133. Arbyn M., Rebolj M., De Kok I.M., Fender M., Becker N., O'Reilly M., et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009, 45:2671-2678.
134. Cavefors AS. Vaccination mot HPV inom skolhälsevården [Vaccination against HPV within school healthcare]. Available from: [last accessed 30.08.11]. http://www.smittskyddsinstitutet.se/upload/smidag/hpv/Hur%20ser%20skolh%C3%A4lsov%C3%A5rden%20p%C3%A5%20det%20praktiska%20genomf%C3%B6randet%2C%20Ann-Sofie%20Cavefors%2C%20Utbildningsf%C3%B6rv.%20Trollh%C3%A4ttan%20.pdf.